These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 26005969)
1. Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats. Otunctemur A; Ozbek E; Cakir SS; Dursun M; Cekmen M; Polat EC; Ozcan L; Somay A; Ozbay N Int Braz J Urol; 2015; 41(2):279-87. PubMed ID: 26005969 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of hydrogen sulfide on renal injury in the experimental unilateral ureteral obstruction. Dursun M; Otunctemur A; Ozbek E; Sahin S; Besiroglu H; Ozsoy OD; Cekmen M; Somay A; Ozbay N Int Braz J Urol; 2015; 41(6):1185-93. PubMed ID: 26742979 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney. Otunctemur A; Ozbek E; Cekmen M; Cakir SS; Dursun M; Polat EC; Somay A; Ozbay N Ren Fail; 2013; 35(3):403-10. PubMed ID: 23342977 [TBL] [Abstract][Full Text] [Related]
4. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist. Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892 [TBL] [Abstract][Full Text] [Related]
5. Montelukast protects against renal ischemia/reperfusion injury in rats. Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888 [TBL] [Abstract][Full Text] [Related]
6. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury. Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158 [TBL] [Abstract][Full Text] [Related]
7. Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats. Abdel-Raheem IT; Khedr NF Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):341-53. PubMed ID: 24363042 [TBL] [Abstract][Full Text] [Related]
8. [Effects of reduced glutathione on contents of hydroxyproline and oxidation stress reaction in kidney of unilateral ureteral obstruction in rat]. Na Y; Zhang XX; Zhang XD; Yuan HP; Hu XL; Zheng W; Li G Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):735-8. PubMed ID: 18093431 [TBL] [Abstract][Full Text] [Related]
9. Ulinastatin attenuates renal interstitial inflammation and inhibits fibrosis progression in rats under unilateral ureteral obstruction. Jiang GT; Chen X; Li D; An HX; Jiao JD Mol Med Rep; 2014 Sep; 10(3):1501-8. PubMed ID: 24926571 [TBL] [Abstract][Full Text] [Related]
10. Do Montelukast Sodium and N-Acetylcysteine Have a Nephroprotective Effect on Unilateral Ureteral Obstruction? A Placebo Controlled Trial in a Rat Model. Sunay M; Karakan T; Aydın A; Koca G; Börcek P; Öğüş E J Urol; 2015 Oct; 194(4):1132-7. PubMed ID: 25776910 [TBL] [Abstract][Full Text] [Related]
11. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast. Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745 [TBL] [Abstract][Full Text] [Related]